William P. Janzen

Immunology and Microbiology · Life Sciences

36h-index5.8kcitations152works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Phagocytosis and Immune Regulation(27), Epigenetics and DNA Methylation(22), Computational Drug Discovery Methods(17), Cancer-related gene regulation(16), Genomics and Chromatin Dynamics(10)

Publications152 total

Supplementary Figure 4 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 1 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 3 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Data from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 3 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 5 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Data from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 2 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 2 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 5 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 1 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Supplementary Figure 4 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia <i>In Vitro</i> and <i>In Vivo</i>
2023Open Access
Small-molecule ligands of methyl-lysine binding proteins: Optimization of selectivity for L3MBTL3
Figshare·2021Open Access
A Sensitive Assay Using a Native Protein Substrate for Screening HIV-1 Maturation Inhibitors Targeting the Protease Cleavage Site between the Matrix and Capsid
UNC Libraries·2021Open Access
Discovery of an in Vivo Chemical Probe of the Lysine Methyltransferases G9a and GLP
Figshare·2021· 8 citedOpen Access
AMP Is an Adenosine A 1 Receptor Agonist
UNC Libraries·2020Open Access
Cavitation Enhancing Nanodroplets Mediate Efficient DNA Fragmentation in a Bench Top Ultrasonic Water Bath
UNC Libraries·2020Open Access
Filtration Improves the Performance of a High-Throughput Screen for Anti-Mycobacterial Compounds
UNC Libraries·2020· 1 citedOpen Access
Expression of Ror2 Mediates Invasive Phenotypes in Renal Cell Carcinoma
UNC Libraries·2020Open Access
The Lipid Kinase PIP5K1C Regulates Pain Signaling and Sensitization
UNC Libraries·2020Open Access
page 1 of 8Next →

Frequent Co-authors

Stephen V. Frye(22), Dmitri Kireev(15), Jian Jin(12), Jacqueline L. Norris(10), C.H. Arrowsmith(8), Peter J. Brown(8), Tim J. Wigle(8), J. Martin Herold(8), Victoria Korboukh(7), Xiaodong Wang(7), Jack B. Jiang(6), Deborah DeRyckere(6), Debra M. Hunter(6), Susan Sather(6), H. Shelton Earp(6), Douglas K. Graham(6), Jacqueline Norris‐Drouin(6), Lawrence M. Ballas(5), Masoud Vedadi(5), Lindsey I. James(5)